Inhibition of NOX4 could therefore mitigate the pathogenesis of AF, suggesting that NOX4 targeting could offer a potential strategy for controlling the progression of this arrhythmia [114] (Table 4). This evidence concerns the gene NOX4 and Arrhythmia.